|
TBC1D8B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44169137633799E-15 |
| Normal-vs-Stage2 |
2.2088000317666E-09 |
| Normal-vs-Stage3 |
2.68007838144513E-13 |
| Normal-vs-Stage4 |
2.50129916778974E-11 |
| Stage1-vs-Stage2 |
3.834600E-01 |
| Stage1-vs-Stage3 |
3.392000E-01 |
| Stage1-vs-Stage4 |
1.522560E-01 |
| Stage2-vs-Stage3 |
8.739200E-01 |
| Stage2-vs-Stage4 |
6.822200E-01 |
| Stage3-vs-Stage4 |
5.117000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.246480E-04 |
| Normal-vs-Asian |
7.44979999911521E-09 |
| Caucasian-vs-AfricanAmerican |
2.938800E-01 |
| Caucasian-vs-Asian |
8.879000E-01 |
| AfricanAmerican-vs-Asian |
4.321200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.09994260763824E-12 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
1.881240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.89379631368547E-12 |
| Normal-vs-Age(41-60Yrs) |
2.52020626589911E-14 |
| Normal-vs-Age(61-80Yrs) |
1.65356617287671E-12 |
| Normal-vs-Age(81-100Yrs) |
2.340500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.486400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.139900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.803600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.136600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.257600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.647600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.023800E-01 |
| Classical-VS-Follicular |
1.022230E-01 |
| Classical-VS-Other |
1.146970E-01 |
| Classical-VS-Normal |
1.21720000745285E-09 |
| Tall-VS-Follicular |
8.523800E-01 |
| Tall-VS-Other |
2.984200E-01 |
| Tall-VS-Normal |
1.14660003713851E-09 |
| Follicular-VS-Other |
3.590400E-01 |
| Follicular-VS-Normal |
1.30360167105437E-11 |
| Other-VS-Normal |
1.958710E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33146835171283E-15 |
| Normal-vs-N1 |
8.08449973632719E-11 |
| N0-vs-N1 |
6.896600E-01 |
|
|
